Advancing patient care

Overview

Committed to developing and commercializing neurology, orphan, and specialty therapies

Assertio products

Product Indication Phase 1/2 Phase 3 Registration Marketed
Gralise® Postherpetic neuralgia X X X X
Cambia® Migraine attacks X X X X
Zipsor® Mild/moderate acute pain X X X X
Cosyntropin X X O O

Partner products

Product Indication Phase 1/2 Phase 3 Registration Marketed
Nucynta® ER
(Collegium)
Moderate/severe chronic pain X X X X
Nucynta®
(Collegium)
Moderate/severe acute pain X X X X
Xartemis XR
(Mallinckrodt)
Acute severe pain X X X X
IW-3718
(Ironwood)
Gastroesophageal reflux disease (GERD) X X O O